Abstract
Thromboxane (Tx) A2 is a platelet agonist, smooth muscle cell constrictor, and mitogen1. Urinary Tx metabolite (Tx-M) excretion is increased in syndromes of platelet activation and early in both normal pregnancies and in pregnancy-induced hypertension2,3. A further increment occurs in patients presenting with severe preeclampsia, in whom Tx-M correlates with other indices of disease severity4. TxA2 exerts its effects through a membrane receptor (TP), of which two isoforms (α and β; refs. 5,6) have been cloned. Overexpression of TP in the vasculature under the control of the pre-proendothelin-1 promoter7 results in a murine model of intrauterine growth retardation (IUGR), which is rescued by timed suppression of Tx synthesis with indomethacin. IUGR is commonly associated with maternal diabetes or cigarette smoking, both conditions associated with increased TxA2 biosynthesis8,9.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
FitzGerald, G.A. in Cecil Loeb's Textbook of Medicine, 20th edn (eds. Wyngaarden, J.B., Smith, L.H., Bennett, J.C.) 1187–1193. W.B. (Saunders, Philadelphia,1995).
Fitzgerald, D.J., Catella, F. & FitzGerald, G.A. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315, 983–989 (1986).
Fitzgerald, D.J., Mayo, G., Catella, F., Entman, S.S. & FitzGerald, G.A. Increased thromboxane biosynthesis in pregnancy derives largely from platelets. Am. J. Obs. Gynecol. 157, 325–330 (1987).
Fitzgerald, D.J., Rocki, W., Murray, R., Mayo, G. & FitzGerald, G.A. Thromboxane A2 synthesis in pregnancy induced hypertension. Lancet 335, 751–754 (1990).
Nusing, R.M. et al. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. J. Biol. Chem. 268, 25253–25259 (1993).
Raychowdhury, M.K. et al. Additions and corrections to alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A receptor. J. Biol. Chem. 30, 19256–19261 (1995).
Harats, D. et al. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-I promoter. J. Clin. Invest. 95, 1335–1344 (1995).
Davi, G. et al. Thromboxane biosynthesis and platelet function in Type II diabetes mellitus. N. Engl. J. Med. 322, 1769–1774 (1990).
Nowak, J., Murray, J.J., Oates, J.A. & FitzGerald, G.A. Biochemical evidence of a chronic abnormality in platelet and vascular function in apparently healthy chronic cigarette smokers. Circulation 76, 6–14 (1987).
Loeb, A.L. & Longnecker, D.E. Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. Am. J. Physiol. 262, H1494–1500 (1992)
Krege, J., Hodgin, J., Hagamin J. & Smithies, O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25, 1111–1115 (1995).
Talamantes, F. & Ogren, L. Prolactins of pregnancy and their cellular source. Int. Rev. Cytol 112, 1–65 (1988).
Lim, H. et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91, 197–208 (1997).
Sugimoto, Y. et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 277, 681–683 (1997).
Ghidini, A. Idiopathic fetal growth restriction: a pathophysiological approach. Obstet. Gynec. Surv. 51, 376–382 (1996).
Wigglesworth, J.A. Experimental growth retardation in the foetal rat. J. Path. Bact. 88, 1 (1964).
Roy-Clavel, E., Picard, S., St-Louis, J. & Brochu, M. Induction of intrauterine growth restriction with a low-sodium diet fed to pregnant rats. Am. J. Obsetet. Gynecol 180, 608–613 (1999).
Van Feijn, H.P., Kaylor, W.M., & Nicola, K.R. Induction of severe intrauterine growth retardation in the Sprague-Dawley rat. Am. J. Ostet. Gynecol. 137, 43 (1980).
Johnston, B.M. Fetal growth retardation and increased placental weight in the spontaneously hypertensive rat. Reprod. Fertil. Dev. 7, 639–645 (1995).
Parent, J.L., Labrecque, P., Orsini, M. & Benovic, J.L. Internalization of the TxA2 receptor and isoforms. Role of the differentially spliced COOH terminus in agonist-promoted receptor. J. Biol. Chem. 274, 8941–8948 (1999).
Vezza, R., Habib, A. & FitzGerald, G.A. Differential coupling of the thromboxane receptor isoforms with Gh. J. Biol. Chem. 274, 12774–12779 (1999).
McCormick, M.C. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 312, 82–90 (1985).
Barker, M., Robinson, S., Osmond, C. & Barker, D.J. Birth weight and body fat distribution in adolescent girls. Arch. Dis. Child. 77, 381–383 (1997).
Acknowledgements
This work was supported by grants from the National Institutes of Health (HL 54500, HL 57847 and HD 29946) and an American Heart Association (Mid-Atlantic Research Consortium) grant-in-aid. G.A.F. is the Robinette Foundation Professor of Cardiovascular Medicine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rocca, B., Loeb, A., Strauss, J. et al. Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation. Nat Med 6, 219–221 (2000). https://doi.org/10.1038/72334
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/72334
This article is cited by
-
Role for the thromboxane A2 receptor β-isoform in the pathogenesis of intrauterine growth restriction
Scientific Reports (2016)
-
The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis
Cancer and Metastasis Reviews (2011)
-
Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase—deficient mice
Nature Medicine (2005)